Literature DB >> 76402

Serum levels of 8-methoxypsoralen 2 hours after oral administration.

I Steiner, T Prey, F Gschnait, J Washüttl, F Greiter.   

Abstract

Serum levels of 8-methoxypsoralen (8-MOP) were determined 2 hours after oral administration and found to vary considerably among psoriatic patients. There was no definite correlation between the 8-MOP serum level, the dose of 8-MOP/kg body weight ingested, and the minimal phototoxic UVA dose.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 76402

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


  7 in total

1.  Serum level profiles of 8-methoxypsoralen after oral administration.

Authors:  I Steiner; T Prey; F Gschnait; J Washüttl; F Greiter
Journal:  Arch Dermatol Res       Date:  1977-09-27       Impact factor: 3.017

2.  [8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].

Authors:  V Nitsche; M Raff; H Bardach
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

3.  Intraindividual variations of 8-methoxypsoralen plasma levels.

Authors:  M Schäfer-Korting; H C Korting
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method.

Authors:  H C Korting; M Schäfer-Korting; E Roser-Maass; E Mutschler
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Variations in skin photosensitization during repeated oral 8-methoxypsoralen medication.

Authors:  C T Jansén; G Wilén; R Paul
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 6.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

7.  Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brands.

Authors:  K E Andersen; T Menne; M Gammeltoft; N Hjorth; E Larsen; P Solgaard
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.